Frank Steven 4

What Happened

• Frank Steven, a director of Precigen, reported the conversion/settlement of 71,839 restricted stock units (RSUs) into 71,839 shares on March 13, 2026. The filing shows an "exercise or conversion of derivative" (transaction code M) acquiring 71,839 shares and a corresponding derivative disposition of 71,839 shares at $0.00. No cash price or dollar value is reported for the shares in the filing.

Key Details

• Transaction date: March 13, 2026; Form 4 filed March 16, 2026 (timely, within required reporting window).
• Transaction code: M (exercise or conversion of a derivative security).
• Shares acquired: 71,839; Disposition reported: 71,839 at $0.00 (per filing).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes: F1—each RSU represents a contingent right to one share of common stock; F2—the RSUs vested in full on March 13, 2026.
• No 10b5-1 plan, tax-withholding, or cash proceeds are indicated in the provided text.

Context

• This filing reflects RSUs vesting and conversion into common stock (an acquisition/award for the insider), not an open-market purchase or sale. The reported $0.00 disposition is consistent with conversion/settlement reporting (the filing does not show any cash proceeds). Such award/vesting transactions are routine compensation events and are generally different from purchases or sales that signal trading intent.